Alan Braly has a diverse work experience across various healthcare and consulting firms. Alan has held roles such as Senior Director of Global Portfolio Strategy at Foundation Medicine. Alan has also worked as a Faculty Advisor at the Massachusetts Institute of Technology, a Start-up Advisor/Mentor and Independent Consultant at Knollcrest Medical, and as Co-Founder and CEO (2017-2018) and Advisor (2018-2019) at Obsidio Medical. Braly was also a Co-Founder at Silverstone Biosciences. Additionally, they have experience as a Blavatnik Fellow at Harvard Business School and as a Director at Health Advances. Alan has also worked as a Business Development Consultant at Rogers Sciences, MBA Intern in Global Commercial Strategy at Biogen Idec, and Senior Biomedical Engineer at Medtronic.
Alan Braly received a Bachelor of Science degree in Biomedical Engineering from The Johns Hopkins University from 1998 to 2002. Alan then pursued further education and obtained a Master of Business Administration degree in Business from Harvard Business School from 2008 to 2010. Additionally, they earned a Master of Science degree in Health Sciences and Technology (HST) from the Massachusetts Institute of Technology from 2008 to 2011.
January 1, 2023 - present
2019